Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 7
2014 2
2017 1
2020 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer.
Ronden MI, Bahce I, Hashemi SMS, Dickhoff C, de Haan PF, Becker A, Spoelstra FOB, Dahele MR, Ali R, Tiemessen MA, Tarasevych S, Maassen van den Brink K, Haasbeek CJA, Daniels JMA, van Laren M, Verbakel WFAR, Senan S. Ronden MI, et al. Among authors: de haan pf. Lung Cancer. 2021 Feb;152:149-156. doi: 10.1016/j.lungcan.2020.12.019. Epub 2020 Dec 24. Lung Cancer. 2021. PMID: 33418430
Relationship between Treatment Plan Dosimetry, Toxicity, and Survival following Intensity-Modulated Radiotherapy, with or without Chemotherapy, for Stage III Inoperable Non-Small Cell Lung Cancer.
Remmerts de Vries IF, Ronden MI, Bahce I, Spoelstra FOB, De Haan PF, Haasbeek CJA, Lissenberg-Witte BI, Slotman BJ, Dahele M, Verbakel WFAR. Remmerts de Vries IF, et al. Among authors: de haan pf. Cancers (Basel). 2021 Nov 25;13(23):5923. doi: 10.3390/cancers13235923. Cancers (Basel). 2021. PMID: 34885034 Free PMC article.